Under construction – not a live service
Sign in
Taking people in FranceNo phase

Learning New Information Together in People With Memory and Language Disorders

Studies how learning with others affects memory in people with Alzheimer's or semantic aphasia.

Key facts

Who runs it
University Hospital, Caen
Where
Caen, FranceSee the site
Trial code
Registry title
Memory and Social Interactions
Status
Recruiting
People taking part
192 people, planned
Started
10 Mar 2023
Expected to end
31 Dec 2026
Type of study
Observational, 4 groups
Treatments tested
  • Learning new information
Record updated
20 September 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for couples in which one person has Alzheimer's disease or the semantic variant of primary progressive aphasia, or has no memory complaints. The partner must be a person without cognitive complaints.

Age
People with Alzheimer's disease, semantic primary progressive aphasia, or no cognitive complaint: 50 to 85 years. Partners: over 18 years.
Sex
All sexes can join.
Disease stage
Probable Alzheimer's disease dementia with memory loss as the main problem, or the semantic variant of primary progressive aphasia. A comparison group has no cognitive complaint.
Earlier treatment
Not in a therapeutic drug trial at the same time. No medicines that may affect thinking or brain function, judged case by case by the investigator.

Main reasons for not taking part

  • Uncorrected vision or hearing problems that would interfere with the study
  • History of stroke, epilepsy or head injury with loss of consciousness for more than one hour
  • History of long-term alcohol or drug abuse
  • Serious psychiatric illness within the last 10 years
  • Cancer within the past 5 years, except squamous cell carcinoma

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • AD group: Age between 50 and 85 years, Diagnosis of probable Alzheimer's disease dementia with amnestic presentation and documented decline following the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
  • SPPA group: Age between 50 and 85 years, Diagnosis of the semantic variant of primary progressive aphasia following the classification of primary progressive aphasia and its variants
  • HC group: Age between 50 and 85 years, Matched in age and sociocultural status with one of the AD or SPPA patients, No cognitive complain, No recent reduction in social or cognitive activities, No contraindication to MRI examination
  • Partners: Age over 18 years of age , No cognitive complaints, Social interactions of at least two hours per week for at least 5 years with one of the individuals of the other three groups

Who cannot take part

  • Concurrent participation in a therapeutic drug trial
  • Use of medications that may affect cognitive and/or brain function. Given the number of molecules involved and the dosages, the principal investigator will judge on a case-by-case basis whether regular use of certain medications will interfere with the study
  • Uncorrected visual and/or auditory disorders that are sufficiently significant to interfere with the protocol
  • History of neurological disorders (stroke, epilepsy, head trauma with loss of consciousness for more than one hour)
  • History of chronic alcoholism or drug abuse
  • History within the last 10 years of a clinically significant major psychiatric disorder
  • Cancer within the past 5 years, except for squamous cell carcinoma
  • Deprivation of liberty by judicial or administrative decision
  • Not being a member of a social security system

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 85 years old?

Where in France

  • Caen University HospitalCaen, FranceContact: Olivier Martinaud, MD, PhDTaking people

About the trial

What the trial wants to find out

Memory and social interaction are intimately linked. On the one hand, social interaction is a privileged context for learning, and on the other hand, appropriate social interactions involve remembering the partners encountered and previous exchanges. People with Alzheimer's disease classic syndrome variant (AD) have a major impairment of episodic memory, while people with the semantic variant of primary progressive aphasia (SPPA) are characterized by semantic disorders in the foreground, associated with changes in their social behavior with a tendency to egocentricity. In both cases, patients frequently have reduced social interactions. Although social interaction situations seem to constitute a privileged learning context, their effectiveness for patients with cognitive disorders must be evaluated and the conditions under which they are effective must be established. The main objective of this study is to determine whether social interaction constitutes a beneficial context for learning new information and whether the presence of social behavior disorders alters this benefit. More broadly, the goal is to better understand the mechanisms underlying the possible beneficial effect of learning in social contexts and to clarify the links between memory performance in different social contexts, cognitive disorders, social behavioral changes and personality traits. Finally, a description will be made of the brain substrates associated with memory performance obtained during learning in social contexts in order to investigate their particularities. Thirty couples each including a person with AD, 16 couples each including a person with SPPA and 46 couples of persons without cognitive complaints (HC), one of which will be matched in gender and age to one of the patients, will be included in the study. Participants will perform image location learning in a grid, in three social contexts in which both members of the couple are involved: 1) simple presence of others, 2) by observation and 3) in collaboration. A psychometric assessment including social cognition and classical tests assessing memory, and questionnaires concerning global executive functioning, social behavior and personality will be offered to all participants. Patients in the AD and SPPA groups and the matched individual in the HC group will undergo anatomical and functional brain magnetic resonance imaging (MRI).

The 4 groups in the trial

  • AD group

    30 individuals aged between 50 and 85 years with probable Alzheimer's disease dementia with amnestic presentation and documented decline following the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

    Treatment: Learning new information

  • SPPA group

    16 individuals aged between 50 and 85 years with the semantic variant of primary progressive aphasia following the classification of primary progressive aphasia and its variants.

    Treatment: Learning new information

  • HC group

    46 individuals without cognitive complain.

    Treatment: Learning new information

  • Partners

    92 individuals without cognitive complaints. Each of these individuals will partner with one of the members of the experimental groups to carry out learning in social contexts.

    Treatment: Learning new information

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Memory and Social Interactions: Study in Alzheimer's Disease and Semantic Progressive Aphasia
Plain-language title
Learning New Information Together in People With Memory and Language DisordersGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT05800028, who can take part
Record updated
20 September 2024